GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.050
-0.040 (-1.91%)
At close: Sep 25, 2026, 4:00 PM EDT
2.080
+0.030 (1.46%)
Pre-market: Sep 28, 2026, 7:47 AM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $4.48 million as of September 25, 2026. Its market cap has decreased by -16.35% in one year.
Market Cap
4.48M
Enterprise Value
-6.42M
1-Year Change
-16.35%
Ranking
Category
Stock Price
$2.05
ChartMarket Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $4.48M, a decrease of -82.28%. That is a compound annual growth rate of -39.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.48M | 79.41% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexaria Bioscience | 5.42M |
| Can-Fite BioPharma | 4.87M |
| PharmaCyte Biotech | 4.73M |
| Dermata Therapeutics | 4.59M |
| Calidi Biotherapeutics | 4.18M |
| 60 Degrees Pharmaceuticals | 4.11M |
| Cadrenal Therapeutics | 4.10M |
| Onconetix | 4.07M |